Immunoglobulin

BIOLOGICAL11 trials

Sponsors

Sato Yoshiaki, National Eye Institute (NEI), Instituto Grifols, S.A., Brigham and Women's Hospital, Assistance Publique - Hôpitaux de Paris

Conditions

Alzheimer's DiseaseAntibiotic ProphylaxisAntibody-mediated RejectionB Cell Acute Lymphoblastic Leukemia (B-ALL)B Cell LymphomaCIDP - Chronic Inflammatory Demyelinating PolyneuropathyChimeric Antigen Receptor T-cell TherapyHumoral Rejection

Phase 2

A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease

CompletedNCT01561053

Instituto Grifols, S.A.Alzheimer's Disease

Start: 2012-04-19End: 2018-03-06Updated: 2019-07-31

Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation

TerminatedNCT01895127

Brigham and Women's HospitalAntibody-mediated Rejection, Humoral Rejection

Start: 2013-11-30End: 2016-04-30Updated: 2017-09-21

Immunotherapy and Paraneoplastic Neurological Syndromes

CompletedNCT02343211

Assistance Publique - Hôpitaux de ParisParaneoplastic Neurological Syndromes

Start: 2013-11-30End: 2016-12-31Target: 17Updated: 2017-11-06

Phase 3

Intravenous Immunoglobulin Therapy in Optic Neuritis

CompletedNCT00000117

National Eye Institute (NEI)Optic Neuritis

Start: 1995-08-31End: 1997-12-31Updated: 2009-09-17

A Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalities in Taiwanese Refractory Kawasaki Disease (RAST Study)

National Taiwan University HospitalKawasaki Disease, Steroid, Immuoglobulin

Start: 2013-10-17End: 2020-12-31Target: 100Updated: 2017-06-27

Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency

WithdrawnNCT03492710

Green Cross CorporationPrimary Immune Deficiency Disorder

Start: 2019-04-30End: 2019-04-30Updated: 2020-07-07

Randomised Evaluation of COVID-19 Therapy

RecruitingNCT04381936

University of OxfordPneumonia

Start: 2020-03-19End: 2038-09-30Target: 70000Updated: 2026-04-21

Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B Cell Acute Lymphoblastic Leukemia or a B Cell Lymphoma

Not yet recruitingNCT07754682

Assistance Publique - Hôpitaux de ParisChimeric Antigen Receptor T-cell Therapy, B Cell Acute Lymphoblastic Leukemia (B-ALL), B Cell Lymphoma +2

Start: 2026-09-01End: 2029-09-01Target: 228Updated: 2026-08-10

Phase 4

The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss

Shanghai First Maternity and Infant HospitalRecurrent Pregnancy Loss

Start: 2014-10-31End: 2018-12-22Target: 500Updated: 2017-03-08

Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)

RecruitingNCT04589299

University of AarhusCIDP - Chronic Inflammatory Demyelinating Polyneuropathy

Start: 2020-06-04End: 2030-12-31Target: 60Updated: 2024-05-17

Unknown Phase

Comparison of 10% Immunoglobulin Dosing Times for Kawasaki Disease

RecruitingJPRN-jRCT1041230181

Sato YoshiakiKawasaki Disease Kawasaki disease

Start: 2024-03-29Target: 560Updated: 2026-06-29

Related Papers

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

2025-08-282 citations

Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

2025-05-151 citations

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

2025-02-124 citations

Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospitalised with COVID-19 in England

Trials2024-06-294 citations

Post-Hoc Assessment of Cognitive Efficacy in Alzheimer’s Disease Using a Latent Growth Mixture Model in AMBAR, a Phase 2B Randomized Controlled Trial

Current Alzheimer Research2024-05-01

Application of a Novel Endpoint Staging Framework: Proof of Concept in the AMBAR Study

Journal of Alzheimer s Disease2024-03-13

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

2024-01-317 citations

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.

2024-01-2218 citations

Dapagliflozin in patients with critical illness: rationale and design of the DEFENDER study.

2023-12-222 citations

Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trial.

2023-12-065 citations

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

2023-10-1823 citations

The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial.

2023-07-2815 citations

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

2023-04-1384 citations

Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial.

2023-02-0331 citations

Challenges of using external data in clinical trials- an illustration in patients with COVID-19

BMC Medical Research Methodology2022-12-154 citations

FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities

Clinical Drug Investigation2022-09-293 citations

Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study.

2022-09-2211 citations

Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer’s disease: additional results from the AMBAR study

European Journal of Nuclear Medicine and Molecular Imaging2022-07-2211 citations

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.

2022-07-01233 citations

Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial.

2022-05-2010 citations

24 more papers not shown